A B S T R A C T The objective of this investigation was to determine whether heterogeneity of plasma renin substrate could be observed in states of steroid excess and various forms of hypertensive disease. In states of stimulated renin substrate production by estrogens or glucocorticoids, multiple forms of renin substrate were apparent when stimulation was excessive. Stimulation of substrate production caused by uremia associated with hypertension showed similar results. None, or only trace quantities of the additional forms of renin substrate were evident in subjects with normal or suppressed levels of plasma renin substrate. The additional forms of renin substrate could be distinguished from the normal form on the basis of crossreactivity with a specific antiserum to the normal form, electrophoretic mobility, and kinetic rate constants. Differences in rate constants of the various forms of plasma renin substrate may account for the altered rate of the renin reaction associated with several states of hypertension. In plasma of patients with renovascular hypertension, significant quantities of a protein which cross-reacted with the antiserum but could not generate angiotensin I were observed. INTRODUCTION We have previously described the purification of renin substrate from normal human plasma (1) and the development of a direct radioimmunoassay for this protein (2). The direct assay for renin substrate in normal human plasma was validated by demonstrating a 1:1 correlation to substrate measured by the generation of angiotensin I by prolonged incubation with exogenous homologous renin (indirect method). Results of preliminary experiments indicated, however, that in plasma samples in which renin substrate concentration was elevated at least 2 SD above normal as measured by angiotensin I generation, the direct as-
INTRODUCTION
We have previously described the purification of renin substrate from normal human plasma (1) and the development of a direct radioimmunoassay for this protein (2) . The direct assay for renin substrate in normal human plasma was validated by demonstrating a 1:1 correlation to substrate measured by the generation of angiotensin I by prolonged incubation with exogenous homologous renin (indirect method). Results of preliminary experiments indicated, however, that in plasma samples in which renin substrate concentration was elevated at least 2 SD above normal as measured by angiotensin I generation, the direct asDr. Hidaka's present address is the University of Tokyo, First Department of Medicine, Tokyo, Japan.
Received for publication 14 November 1977 and in revised form 27 March 1978. say underestimated the renin substrate concentration suggesting that other forms of renin substrate were present in these plasmas which could be cleaved by renin to generate angiotensin I, but did not crossreact with the antiserum produced against the renin substrate of normal plasma (2) . The following study examines the various forms of plasma renin substrate in several clinical states associated with hypertension and in patients receiving agents known to stimulate renin substrate synthesis.
METHODS
Blood was collected in 15 mM EDTA and plasma samples were stored at -20°C. Plasma renin substrate was quantitated by two methods: (a) direct, a detailed description of this method has previously been reported by Eggena et al. (2) . Briefly, '25I-labeled renin substrate and its specific antiserum (produced in rabbit) were added to a diluted plasma sample and equilibrated at 4°C for 18 h. The bound and free antigens are separated after a second equilibration with goat anti-rabbit gamma globulin by centrifugation. (b) Indirect, plasma was incubated for 3 h at 37°C in the presence of angiotensinase inhibitors (3) with excess homologous renal renin (4) to convert all renin substrate to angiotensin I (5). Generated angiotensin was quantitated by radioimmunoassay (5) . Plasma renin activity (PRA)' was determined by the method of Barrett et al. (3) . Polyacrylamide gel electrophoresis at pH 4.3 and 8.4 were performed in 7% polyacrylamide (6) . Isoelectric focusing in 7% polyacrylamide was performed according to the method of Lim and Tadayyou (7). Proteins were extracted from 2-mm gel slices in 0.05 Tris-HCl, pH 7.4 with a Gilson Aquagel extractor (Gilson Medical Electronics, Inc., Middleton, Wis.).
RESULTS
Normal and essential hypertensive subjects. Results of the direct and indirect measurement of renin substrate in plasma samples from normotensive subjects and patients with essential hypertension are shown in Fig. 1 . The data indicate a good correlation between the results of the two assay techniques (y = 1.12 x + 4, r = 0.78, P < 0.01, n = 28); no statistically 'Abbreviations used in this paper: PRA, plasma renin activity; Rf, running front ratio. (8, 9) . When the plasma renin substrate levels of these women were below =6,000 ng angiotensin I eq/ml, an excellent linear correlation between both assay methods was obtained (open circles in Fig. 3 , y = 1.08 + 450, r = 0.96, n = 7). However, when substrate concentrations were above this level, closed circles in Fig.  3 , a discrepancy between the two assay methods was evident; the indirect method giving significantly higher plasma substrate concentrations than the direct assay (9,600±3,020 [SD] (Fig. 4) .
Uremia, advanced essential, malignant, and renovascular hypertension. Renin substrate determinations by both methods were performed using plasma normal gel electrophoresis pattern (pH 8.4) was observed in patients with malignant hypertension (n = 5). In eight patients with suppressed renin substrate levels associated with cirrhosis of the liver (Fig. 5) , no abnormalities were evident. Patients with renovascular hypertension were the only subjects to show a different type of discrepancy between assay methods; the direct assay gave higher substrate concentrations than determinations using angiotensin I generation (3,320±480 [SD] vs. 1,840 ±455 [SD] ng angiotensin I eq/ml), Fig. 5 . Polyacrylamide gel electrophoresis of these plasmas at pH 8.4 revealed only the normal renin substrate peak, Rf 0.65 but lacked a 1:1 correspondence. Upon electrophoresis at pH 4.3, however, the direct radioimmunoassay indicated a large quantity of a protein which cross-reacted with the antiserum but did not generate angiotensin I. (Fig. 2D) . The discrepancy observed between direct and indirect assay methods for renin substrate in plasma of patients with renovascular hypertension may, therefore, be attributed to high in vivo concentrations of this immunoreactive protein.
To investigate whether stimulated plasma renin levels comparable to those of patients with renovascular hypertension (PRA > 50 ng angiotensin I/ml per h), could lead to elevated levels of this immunoreactive protein, plasma samples from patients with essential hypertension were compared before and after stimulation of plasma renin by spironolactone. In eight patients, the mean PRA increased from 7.4+2.5 (SD) to 58.7±7.1 (SD) after spironolactone treatment. No statistically significant changes in renin substrate levels were evident and, despite the large increase in PRA, a 1:1 correspondence between the two assay methods was maintained. These results indicate that the level of this immunoreactive protein remains low in these subjects, despite the high levels of circulating renin.
Partial characterization of multiple forms of renin substrate. To obtain an estimate of the rates of angiotensin I generation with the various forms of renin substrate, polyacrylamide gel fractions were pooled and equal quantities of each substrate form were incubated for 20 min at 37°C in the presence of homologous renal renin. In this 20-min time period, 15.6±4.7% of the major normal substrate (I) was consumed as compared to 3.6+1.7% for II (Rf = 0.35) and 34.6+3.2% for III (Rf = 0.16), indicating an accelerated rate of angiotensin production from form III in comparison with the normal renin substrate, form I. The effects on the renin reaction ofthe immunoreactive protein from the renovascular hypertensive subjects were also studied. This protein fraction isolated from several electrophoresis runs at pH 4.3 was pooled and increasing quantities were added to normal plasma. The inhibition of PRA is shown in Fig. 6 ; its influence on the rate of the renin reaction is also shown in Fig. 6 . The data indicate that this protein acts as a competitive inhibitor of the renin reaction.
DISCUSSION
As shown in the present report, the lack of a 1:1 correspondence between the two methods for substrate quantitation, in certain subjects has led us to the discovery of multiple forms of renin substrate in human plasma. Multiple peaks of renin substrate activity have also been recently reported by other investigators (10, 11) . In our studies, a lower estimate of plasma renin substrate concentration by direct radioimmunoassay compared to angiotensin I-generating capacity, was observed mainly in plasmas with elevated renin substrate levels. In these cases, plasma renin substrate was found to be heterogenous by either polyacrylamide gel electrophoresis or isoelectric focusing. Underestimation by the direct assay was most pronounced in those women on oral contraceptives with the highest plasma renin substrate concentrations. A corollary observation was made in women during the third trimester of pregnancy. Underestimation by the direct assay and multiple forms of renin substrate, evident during the last trimester, were no longer apparent postpartum, when renin substrate levels had returned to normal. Heterogeneous renin substrate was also evident in certain pathological states. The uremic patients, on chronic hemodialysis having severe renal damage and elevated plasma renin substrate levels (3,960+1,340 [SD] vs. 2,110±790 [SD] for normal subjects) also demonstrated multiple forms of renin substrate. An elevation of renin substrate levels in anephric or hemodialysis patients in the terminal stages of chronic renal failure has previously been reported (12) . The present study also demonstrates that multiple forms of renin substrate are present not only in patients with high plasma estrogen levels, but also in patients receiving glucocorticoids.
In contrast to the above observations, overestimation of renin substrate levels by the direct assay due to a circulating immunoreactive renin substrate-like substance from which angiotensin I could not be generated by incubation with added homologous renin was found in statistically significant quantities, only in the plasma of patients with renovascular hypertension. We suggest that this protein is desangiotensin I renin substrate because the plasma concentration of this protein was (a) shown to increase after incubation with renin, (b) cross-reacted completely with the antiserum to renin substrate and (c) acted as a competitive inhibitor of the renin reaction. Although the physiological function of this protein is not known, it may be suggested that it acts as a feedback control mechanism for partial suppression of the renin reaction in plasma of patients with renovascular hypertension. This feedback mechanism would be ofgreatest significance in renovascular hypertension where substantial quantities of this protein were found to be circulating in plasma. Furthermore, in other types of hypertension, including essential hypertensive patients with high renin levels, acutely stimulated by spironolactone to plasma concentrations equivalent to those observed in renovascular hypertension, no significant quantities of this circulating immunoreactive renin inhibitor were evident. These results indicate, therefore, a possible adaptive alteration in the degradation process of this protein in renovascular hypertension.
We have also demonstrated in this study, new forms of renin substrate which are structurally different from the normal form (Rf = 0.65) because they do not crossreact with the antibody specific for the normal form and differ in isoelectric points and electrophoretic mobilities. Furthermore, the new forms of renin substrate have altered kinetic parameters in the presence of added homologous renin.
In conclusion, the data support the postulate that stimulation of plasma renin substrate by either estrogens, glucocorticoids, or unknown factors such as observed in uremia may lead to the production of structurally new forms of renin substrate. Although the normal form of substrate is the major renin substrate form in all plasmas, the new forms of substrate may have a significant effect on the overall renin reaction in plasma because form III (Rf = 0.16) appears to lead to an accelerated rate of angiotensin production and form II (Rf = 0.35) decreases this rate. These new substrate forms may, therefore, possibly account for the altered kinetics of the renin reaction observed in some hypertensive states (13, 14) .
